Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Raisman-Vozari

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Brain Research. Molecular Brain Research|December 31, 1996
Effect of the weaver mutation on the expression of dopamine membrane transporter, tyrosine hydroxylase and vesicular monoamine transporter in dopaminergic neurons of the substantia nigra and the ventral tegmental areaC Adelbrecht, Y Agid, R Raisman-Vozari
Drug Safety|December 20, 1999
Levodopa in Parkinson's disease: neurotoxicity issue laid to rest?M G Murer, R Raisman-Vozari, O Gershanik
Progress in Neurobiology|October 21, 2000
Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's diseaseM G Murer, Q Yan, R Raisman-Vozari
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1989
Striatal phosphoproteins in Parkinson disease and progressive supranuclear palsyJ A Girault, R Raisman-Vozari, Y Agid, et al.
Neuroreport|March 3, 1997
Absence of neurotoxicity of chronic L-DOPA in 6-hydroxydopamine-lesioned ratsG Dziewczapolski, G Murer, Y Agid, et al.
Neuroscience|July 18, 2006
Regional brain variations of cytochrome oxidase activity and motor coordination in Girk2(Wv) (Weaver) mutant miceC Strazielle, V Deiss, L Naudon, et al.
Synapse (New York, N.Y.)|September 1, 1995
Time-course of modifications elicited by reserpine on the density and mRNA synthesis of the vesicular monoamine transporter, and on the density of the membrane dopamine uptake complexL Naudon, I Leroux-Nicollet, R Raisman-Vozari, et al.
Brain Research. Molecular Brain Research|July 1, 1997
Differential regional effects of long-term L-DOPA treatment on preproenkephalin and preprotachykinin gene expression in the striatum of 6-hydroxydopamine-lesioned ratP Salin, G Dziewczapolski, O S Gershanik, et al.
Neuropharmacology|March 23, 2000
Reserpine or chronic paroxetine treatments do not modify the vesicular monoamine transporter 2 expression in serotonin-containing regions of the rat brainC Vilpoux, I Leroux-Nicollet, L Naudon, et al.
Brain Research|February 19, 1996
Dopaminergic sprouting in the rat striatum after partial lesion of the substantia nigraV Blanchard, P Anglade, G Dziewczapolski, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Brain Research. Molecular Brain Research|December 31, 1996
Effect of the weaver mutation on the expression of dopamine membrane transporter, tyrosine hydroxylase and vesicular monoamine transporter in dopaminergic neurons of the substantia nigra and the ventral tegmental areaC Adelbrecht, Y Agid, R Raisman-Vozari
Drug Safety|December 20, 1999
Levodopa in Parkinson's disease: neurotoxicity issue laid to rest?M G Murer, R Raisman-Vozari, O Gershanik
Progress in Neurobiology|October 21, 2000
Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's diseaseM G Murer, Q Yan, R Raisman-Vozari
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1989
Striatal phosphoproteins in Parkinson disease and progressive supranuclear palsyJ A Girault, R Raisman-Vozari, Y Agid, et al.
Neuroreport|March 3, 1997
Absence of neurotoxicity of chronic L-DOPA in 6-hydroxydopamine-lesioned ratsG Dziewczapolski, G Murer, Y Agid, et al.
Neuroscience|July 18, 2006
Regional brain variations of cytochrome oxidase activity and motor coordination in Girk2(Wv) (Weaver) mutant miceC Strazielle, V Deiss, L Naudon, et al.
Synapse (New York, N.Y.)|September 1, 1995
Time-course of modifications elicited by reserpine on the density and mRNA synthesis of the vesicular monoamine transporter, and on the density of the membrane dopamine uptake complexL Naudon, I Leroux-Nicollet, R Raisman-Vozari, et al.
Brain Research. Molecular Brain Research|July 1, 1997
Differential regional effects of long-term L-DOPA treatment on preproenkephalin and preprotachykinin gene expression in the striatum of 6-hydroxydopamine-lesioned ratP Salin, G Dziewczapolski, O S Gershanik, et al.
Neuropharmacology|March 23, 2000
Reserpine or chronic paroxetine treatments do not modify the vesicular monoamine transporter 2 expression in serotonin-containing regions of the rat brainC Vilpoux, I Leroux-Nicollet, L Naudon, et al.
Brain Research|February 19, 1996
Dopaminergic sprouting in the rat striatum after partial lesion of the substantia nigraV Blanchard, P Anglade, G Dziewczapolski, et al.
Pageof 5